Log in to save to my catalogue

Trehalose-Based Nucleolipids as Nanocarriers for Autophagy Modulation: An In Vitro Study

Trehalose-Based Nucleolipids as Nanocarriers for Autophagy Modulation: An In Vitro Study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_99ec7833cca74964a6a1113fe93c20df

Trehalose-Based Nucleolipids as Nanocarriers for Autophagy Modulation: An In Vitro Study

About this item

Full title

Trehalose-Based Nucleolipids as Nanocarriers for Autophagy Modulation: An In Vitro Study

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2022-04, Vol.14 (4), p.857

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The Autophagy Lysosomal Pathway is one of the most important mechanisms for removing dysfunctional cellular components. Increasing evidence suggests that alterations in this pathway play a pathogenic role in Parkinson’s disease, making it a point of particular vulnerability. Numerous studies have proposed nanotechnologies as a promising approach fo...

Alternative Titles

Full title

Trehalose-Based Nucleolipids as Nanocarriers for Autophagy Modulation: An In Vitro Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_99ec7833cca74964a6a1113fe93c20df

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_99ec7833cca74964a6a1113fe93c20df

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics14040857

How to access this item